Status:
COMPLETED
Evaluation of an Opioid Decrease Strategy in Chronic
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Brief Summary
Increase in the consumption of analgesics observed in many countries with a mediatic crisis resulting in an increasingly frequent wish of patients to wean themselves from opiates. A recent update (B. ...
Detailed Description
Main objective: Check if the rapid to semi-rapid regimen (- 25 to -60% dosage in 5 days of HDS) of opioid analgesics, without the use of methadone or buprenorphine agonists, in the case of DCNC at the...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- chronic pain patient
- major
- supported at CETD
- Exclusion criteria:
- patient with physical and mental incapacity to participate in the study
Exclusion
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04424459
Start Date
October 1 2019
End Date
July 30 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295